The Johnson & Johnson coronavirus vaccine candidate can prevent COVID-19 complications and death, as the Phase 3 trial’s conclusions have shown.
The drugs require a single shot and can be stored at regular refrigerator temperatures. But the J&J COVID-19 vaccine isn’t as effective as the mRNA drugs from Pfizer/BioNTech and Moderna, which could be seen as a disadvantage.
Dr. Anthony Fauci said in an interview that these comparisons do more harm than good, and he explained this particular vaccine is so important.
Johnson & Johnson announced on Friday the results of its coronavirus vaccine Phase 3 trial, revealing to the world that the drug can prevent severe COVID-19 that leads to hospitalization and death. The vaccine is safe to use and had no serious side-effects during the massive Phase 3 trial. The company also said that the drug will work against the B.1.351 South African mutation, the only new coronavirus strain that has been shown to evade some drugs that are already in use.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.